Black Diamond Therapeutics (BDTX) Other Gross PP&E Adjustments (2018 - 2025)
Black Diamond Therapeutics (BDTX) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with -$25.2 million as the latest value for Q3 2021.
- For the quarter ending Q3 2021, Other Gross PP&E Adjustments fell 212.01% year-over-year to -$25.2 million, compared with a TTM value of -$25.2 million through Sep 2021, down 212.01%, and an annual FY2020 reading of -$9.3 million, down 11708.75% over the prior year.
- Other Gross PP&E Adjustments was -$25.2 million for Q3 2021 at Black Diamond Therapeutics, down from -$10.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $80000.0 in Q4 2019 and bottomed at -$25.2 million in Q3 2021.
- Average Other Gross PP&E Adjustments over 3 years is -$8.3 million, with a median of -$8.7 million recorded in 2020.
- Peak annual rise in Other Gross PP&E Adjustments hit 212.01% in 2021, while the deepest fall reached 12918.52% in 2021.
- Year by year, Other Gross PP&E Adjustments stood at $80000.0 in 2019, then crashed by 11708.75% to -$9.3 million in 2020, then crashed by 171.63% to -$25.2 million in 2021.
- Business Quant data shows Other Gross PP&E Adjustments for BDTX at -$25.2 million in Q3 2021, -$10.5 million in Q2 2021, and -$12.8 million in Q1 2021.